Drug
Privigen
Privigen: highest development phase Phase 3, developed by CSL. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| Privigen (Human normal immunoglobulin G (IgG > 98 % purity)) NCT02374736 | Phase 3 | Kidney Transplantation |
| Privigen NCT01785056 | Not Applicable | Systemic Sclerosis |
Latest
No recent events.
Follow Privigen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.